TRENTON,
N.J., July 3, 2024 /PRNewswire/ --
YOUR LEGAL RIGHTS MAY BE
AFFECTED
There is a proposed settlement in a class-action lawsuit filed
against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert
Company, and Warner-Lambert Company LLC (collectively, "Pfizer")
and Ranbaxy Inc., Ranbaxy Laboratories Limited, and Ranbaxy
Pharmaceuticals, Inc. (collectively, "Ranbaxy"). The lawsuit
claims that Pfizer and Ranbaxy unlawfully kept generic versions of
Lipitor off the market, so consumers and third-party payors paid
more for brand and generic Lipitor than they should have. Pfizer
and Ranbaxy deny they did anything wrong. There has been a
settlement with Pfizer; the lawsuit against Ranbaxy is ongoing. No
one is claiming that Lipitor is unsafe.
Who is included in the Settlement? You may be
included in the Settlement if you purchased, paid, and/or provided
reimbursement for branded Lipitor or generic atorvastatin calcium
and fall within any one of the following definitions:
Third-Party Payor Class ("TPP Class")
All entities that, for consumption by their members, employees,
insureds, participants, or beneficiaries, purchased, paid, and/or
provided reimbursement for some or all of the purchase price of
branded Lipitor or generic atorvastatin calcium, in Arizona, California, Washington, D.C., Florida, Iowa, Kansas,
Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New
Hampshire, New Mexico,
New York, North Carolina, North Dakota, Oregon, South
Dakota, Tennessee,
West Virginia, or Wisconsin (the "Class States"), other than for
resale, at any time during the period from June 28, 2011 through and until December 31, 2012.
Consumer Class
All individuals who purchased, paid, and/or provided
reimbursement for some or all of the purchase price of branded
Lipitor, in the Class States, without the use of a Pfizer co-pay
card, from June 28, 2011 through
November 29, 2011.
All individuals who purchased, paid, and/or provided
reimbursement for some or all of the purchase price of generic
atorvastatin calcium, in the Class States, from November 30, 2011 through December 31, 2012.
A more detailed notice, including the full class definitions,
and who is not included, is available at
www.LipitorAntitrustSettlement.com.
What does the Settlement provide? Pfizer will pay
$35 million into a Settlement Fund
that will pay (1) money to eligible Class Members; (2) notice and
administration costs; (3) service awards to the class
representatives who brought the lawsuit; and (4) attorneys' fees,
costs, and expenses. The full text of the proposed Settlement
Agreement is available at
www.LipitorAntitrustSettlement.com.
How can I get a payment? If you believe you are a
Class Member and want to obtain a share of the Settlement Fund, you
will need to complete and return a Claim Form. The amount of your
payment will depend on the amount of Lipitor or AB-rated generic
versions of Lipitor you purchased and the number of claims that are
filed. The Claim Forms, and information on how to submit them, are
available on the Settlement website at
www.LipitorAntitrustSettlement.com. Claim Forms must be postmarked
(if mailed) or received (if submitted online) on or before
November 29, 2024.
What are my rights? Even if you do nothing, you will be
bound by the Court's decisions. If you want to keep your right to
sue Pfizer yourself, you must exclude yourself from the Class by
August 16, 2024. If you do not
exclude yourself, you may object to the proposed settlement by
August 16, 2024.
The Court will hold a hearing on October 1, 2024 to decide whether to approve
the Settlement, the plan for allocating the Settlement Fund to
Class Members, a request for payment of attorneys' fees of up to
34% of the Settlement Fund, plus costs and expenses, and service
awards to the class representatives. You or your own lawyer may
appear and speak at the hearing at your own expense. The Court may
change these deadlines or the hearing date (and time). Check the
website below for updates. Please do not call the Court or
the Clerk of the Court for information about the
Settlement.
Want More Information?
Go to www.LipitorAntitrustSettlement.com, call
1-888-831-7612, email info@LipitorAntitrustSettlement.com or write
to Claims Administrator 54388, P.O. Box 2694, Portland, OR 97208-2694. The deadlines
contained in this Notice may be amended by Court Order, so check
the Settlement website for any updates. Please do not call the
Court or the Clerk of the Court for information about the
Settlement.
View original
content:https://www.prnewswire.com/news-releases/if-you-purchased-paid-or-provided-reimbursement-for-some-or-all-of-the-price-of-branded-lipitor-or-its-generic-equivalent-atorvastatin-calcium-you-could-get-money-from-a-settlement-302189084.html
SOURCE United States District
Court for the District of New
Jersey